ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv art policy disease medicine politics

Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Medicines for the World
Suerie Moon and Ellen â??t Hoen and Suerie Moon and Ellen â??t Hoen | Oct 1, 2012 | 5 min read
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Turning Points: Making Policy, A Career
Karen Young Kreeger | Jun 9, 2002 | 2 min read
Passion leads many scientists away from the bench and into world policy organizations. But policy making and diplomacy require both art and science, and universities and fellowship programs can help life scientists acquire skills they don't always learn in their labs. Take Achal Bhatt, an analyst in the National Immunization Program (NIP) at the Centers for Disease Control and Prevention (CDC) in Atlanta. As Bhatt worked toward her PhD on mycobacteria, which cause tuberculosis, she became incre
Debt Ceiling Bill May Hurt Science
Tia Ghose | Aug 2, 2011 | 5 min read
The bill to raise the debt ceiling and reduce the deficit would slash billions of dollars for basic scientific and medical research.
2018 in Quotes
Catherine Offord | Dec 24, 2018 | 5 min read
From the effects of political upheaval on research to claims of gene-edited babies, the year has been a tumultuous one for the scientific community.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Supplement: Art Caplan
Karen Pallarito | Jan 1, 2008 | 4 min read
Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of
Special Report
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Catherine Offord | Jun 16, 2020 | 10+ min read
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.
Decisions, Decisions: NIH's Disease-By-Disease Allocations Draw New Fire
Bruce Agnew | Mar 29, 1998 | 8 min read
'BODY-COUNT BUDGETING'? Rep. Ernest Istook (R-Okla.) is concerned that diseases that cost taxpayers the most money may not be getting a proportionate amount of NIH funds. For the third year in a row, the National Institutes of Health came under fire this month for slighting some diseases and favoring more politically correct ills when it parcels out its research-funding billions. "What this whole thing boils down to," NIH director Harold Varmus recently told a special Institute of Medicine (I
Politics Polarizing Issues In Needle-Exchange Study
Steven Benowitz | Feb 2, 1997 | 9 min read
POINTED ASSERTION: Dennis Fisher contends that his clinical trial examining methods of obtaining clean syringes is both ethical and valid. Though a federally appointed panel of scientists and ethicists in December okayed the continuation of a controversial needle-exchange clinical trial at the University of Alaska, Anchorage, questions still linger over the ethical and scientific nature of the study. At the same time, the project offers a view of how science can be politicized. Despite survey

Run a Search

ADVERTISEMENT